Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes

Transpl Int. 2023 May 5:36:11068. doi: 10.3389/ti.2023.11068. eCollection 2023.

Abstract

Using the Scientific Registry of Transplant Recipients, we examined the association between donor-recipient biologic relationship and long-term recipient and allograft survival among glomerulonephritis (GN) patients. Four GN types were studied: membranous nephropathy, IgA, lupus-associated nephritis, and focal segmental glomerulosclerosis (FSGS). We identified all adult primary living-donor recipients between 2000 and 2018 (n = 19,668): related (n = 10,437); unrelated (n = 9,231). Kaplan-Meier curves were generated for the recipient, death-censored graft survival and death with functioning graft through ten years post-transplant. Multivariable Cox proportional hazard models were used to examine the association between the donor-recipient relationship and outcomes of interest. There was an increased risk for acute rejection by 12 months post-transplant among the unrelated compared to the related group in IgA (10.1% vs. 6.5%, p<0.001), FSGS (12.1% vs. 10%, p-0.016), and lupus nephritis (11.8% vs. 9.2%; p-0.049). The biological donor-recipient relationship was not associated with a worse recipient or graft survival or death with functioning graft in the multivariable models. These findings are consistent with the known benefits of living-related-donor kidney transplants and counter the reports of the potential adverse impact of the donor-recipient biologic relationship on allograft outcomes.

Keywords: disease recurrence; glomerulonephritis; graft survival; living related donor; long term outcomes.

MeSH terms

  • Adult
  • Allografts
  • Biological Products*
  • Glomerulonephritis* / complications
  • Glomerulonephritis* / surgery
  • Glomerulosclerosis, Focal Segmental* / surgery
  • Graft Rejection / etiology
  • Graft Survival
  • Humans
  • Immunoglobulin A
  • Kidney Transplantation* / adverse effects
  • Living Donors
  • Risk Factors
  • Transplant Recipients

Substances

  • Biological Products
  • Immunoglobulin A